The most influential leaders in oncology from around Europe will be gathering in London on October 20th to explore and shape the dialogue on cancer.

Add in a crippling economic cost of over one trillion dollars and the need to reinvigorate the fight against this pandemic is becoming ever more apparent. But what will a modern cancer initiative look like?

The Economist Events’ War on Cancer 2015 will bring together the most influential leaders in oncology from around Europe to explore and shape the dialogue on cancer. Pharmaceutical, health care, scientific and government specialists will gather on October 20th at the HAC in London to discuss the leading initiatives in policy and financing, innovation in prevention, treatment and diagnosis and new methods of community engagement.  

This cross-sectoral collaboration to improve the health and wealth of Europe’s nations and people will discuss topic areas including:

The Regulatory Perspective: Rallying The European Community Behind A Multi-Stakeholder Adaptive Licensing Approach: In this presentation Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency will give an update on the status of adaptive licensing and the need for cross-sector involvement to ensure its success. 

Creating A Virtuous Circle In Disease Research And Development: Peter Lebowitz, Head of Global Oncology Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson will discuss how by strengthening relationships and the collaborative spirit between disease areas there is potential to hasten progress throughout the entire disease spectrum. What can the oncology community learn from breakthroughs in the treatment of other diseases and vice versa? 

Cancer In The Workplace-Assessing Costs, Redefining Perceptions And Eliminating Discrimination: As the number of working aged people with cancer increases, the direct impact on the economy and its employers will be increasingly felt. Stuart Fletcher, Chief Executive Officer, Bupa will ask: what role does the employer play in supporting its workers diagnosed with cancer? 

The Summit is sponsored by EY, Elekta, Merck Serono, Novartis Oncology and Varian Medical Systems.

For more information, visit http://www.waroncancer.economist.com or contact: Laurence Allen, Marketing Manager on laurenceallen@economist.com